Now showing items 1-1 of 1
Surrogate endpoint biomarkers for cervical cancer chemoprevention trials
(Wiley Subscription Services, Inc., A Wiley Company, 1995)
Cervical intraepithelia neoplasia (CIN) represents a spectrum of epithelial changes that provide an excellent model for developing chemopreventive interventions for cervical cancer. Possible drug effect surrogate endpoint ...